Last winter, Arbutus Biopharma and Genevant Sciences sued Moderna in Delaware federal court in pursuit of damages over alleged infringement of six patents. Separately, Pfizer is playing defense in German and U.S. patent litigation with Germany's CureVac, which filed a suit in summer 2022.